References

HCP SITE

Welcome Page

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

Role of Vitamin D and Vitamin D Deficiency Page

1. Cashman K et al. Vitamin D status of Irish adults: findings from the National Adult Nutrition Survey. British Journal of Nutrition (2013), 109, 1248-1256.

2. Haroon M and Regan M. Vitamin D deficiency: the time to ignore it has passed. International Journal of Rheumatic Diseases 2010; 13: 318-323.

3. Lips et al. The effect of vitamin D on bone and osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 25, (2011), 585-591.

4.  National Osteoporosis Society (NOS). Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. December 2018. V2.

5. Holick M et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab; July 2011; 96(7): 1911-30.

6. Recommendations Abstracted from the American Geriatrics Society Consensus Statement on Vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc 62: 147-152, 2014.

7. Hanley D et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010, Sep 7; 182(12): 1315-1319.

8. Wagner C et al. Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents. Paediatrics Vol 122: No. 5 November 1, 2008, 1142-1152.

9. Godel J et al. Recommendations for Canadian mothers and infants. Paediatr Child Health 2007; 12(7): 583-9.

10. Tangpricha V et al. . An Update on the Screening, Diagnosis, Management and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab April 2012, 97(4): 1082-1093.

11. http://blogs.longwood.edu/osteomalacia/2012/07/06/what-is-osteomalacia/ accessed 24/10/17

Prevalence of Vitamin D Deficiency page

1. Cashman K et al. Vitamin D status of Irish adults: findings from the National Adult Nutrition Survey. British Journal of Nutrition (2013), 109, 1248-1256.

International Guidelines and Recommendations page

1. https://www.fsai.ie/faq/vitamin_d.html accessed 24th October 2017

2.  National Osteoporosis Society (NOS). Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. December 2018. V2.

3. Holick M et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab; July 2011; 96(7): 1911-30.

4. Recommendations Abstracted from the American Geriatrics Society Consensus Statement on Vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc 62: 147-152, 2014.

5. Hanley D et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010, Sep 7; 182(12): 1315-1319.

6. Wagner C et al. Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents. Paediatrics Vol 122: No. 5 November 1, 2008, 1142-1152.

7. Godel J et al. Recommendations for Canadian mothers and infants. Paediatr Child Health 2007; 12(7): 583-9.

8. Tangpricha V et al. . An Update on the Screening, Diagnosis, Management and Treatment of Vitamin D Deficiency in Individuals with Cystic Fibrosis: Evidence-Based Recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab April 2012, 97(4): 1082-1093. Vitamin D:

Vitamin D3: The Evidence in Adults page

1. Chapuy MC et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. NEJM 1992; 327(23):1637-42.

2. Dawson-Hughes B et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. NEJM 1997; 337 (10):670-6.

3. Hitz MF et al. Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 year of treatment with calcium and vitamin D. Am J Clin Nutr 2007; 86(1):251-9.

4. Bischoff-Ferrari H et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Arch Intern Med. Vol 169 (No. 6) March 23, 2009.

Vitamin D3: The Evidence in Children and Adolescents page

1. McNally JD, Kusum M, Chakraborty P, et al. The association of vitamin D status with pediatric critical illness. Pediatrics. 2012;130(3):429–436.

2. Madden K, Feldman HA, Smith EM, et al. Vitamin D deficiency in critically ill children. Pediatrics. 2012 Sep;130(3):421-8.

3. Whiting SJ, Langlois KA, Vatanparast H, Greene-Finestone LS. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr 2011; 94(1):128-35.

4. Absoud M, Cummins C, Lim MJ, Wassmer E, Shaw N. Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study. PLoS One 2011; 6(7):e22179.

5. Ward KA, Das G, Berry JL et al. Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab 2009; 94(2):559-6.

6. Cashman KD, Hill TR, Cotter AA et al. Low vitamin D status adversely affects bone health parameters in adolescents. Am J Clin Nutr 2008; 87(4):1039-44.

7. Sayers A, Fraser WD, Lawlor DA, Tobias JH. 25-Hydroxyvitamin-D3 levels are positively related to subsequent cortical bone development in childhood: findings from a large prospective cohort study. Osteporos Int 2012; 23(8):2117-28.

Are Vitamin D3 and Vitamin D2 equivalent?

1. Houghton L, Vieth, R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr October 2006, vol 84, no. 4, 694-697.

2. Tjellesen L, Hummer L, Christiansen C, Rødbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner. 1986:1:407-413.

3. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998; 68: 854-858.

4. Bischoff-Ferrari H et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Arch Intern Med. Vol 169 (No. 6) March 23, 2009.

5. National Osteoporosis Society. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. April 2013. V1.1.

About Altavita D3 page

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

5. Ish-Shalom S et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008; 93(9): 3430-3435.

How to take Altavita D3

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

Altavita D3 Safety Profile

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie

Altavita D3 Prescribing Information

1. Consilient Health Ltd, Altavita D3 1,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

2. Consilient Health Ltd, Altavita D3 7,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

3. Consilient Health Ltd, Altavita D3 25,000 IU soft capsules, Summary of product characteristics – available on  medicines.ie

4. Consilient Health Ltd, Altavita D3 25,000 IU oral solution, Summary of product characteristics – available on  medicines.ie